Advertisement
Screener

ImmuCell Corporation (ICCC) ROI

ImmuCell Corporation (ICCC) ROI

  • 2026-06-30: ROI 1.98%.
  • 2026-03-31: ROI -1.44%.
  • 2025-12-31: ROI -2.88%.
  • 2025-09-30: ROI 5.91%.

Complete source-backed roi history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-301.98%
2026-03-31-1.44%
2025-12-31-2.88%
2025-09-305.91%
2025-06-304.44%
2024-12-31-5.67%
2022-12-31-5.04%
2020-09-30-3.20%
2020-06-30-3.54%
2020-03-31-3.39%
2019-12-31-2.82%
2019-09-30-4.38%
2019-06-30-3.76%
2019-03-31-4.04%
2018-12-31-5.75%
2018-09-30-3.51%
2018-06-30-3.77%
2018-03-31-2.32%
2017-12-31-0.40%

Annual ROI

DateROI
2025-12-31-2.88%
2024-12-31-5.67%
2022-12-31-5.04%
2019-12-31-2.82%
2018-12-31-5.75%
2017-12-31-0.40%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92